Needle-Free Drug Delivery Devices Market Report 2026

Needle-Free Drug Delivery Devices Market Overview

• Needle-Free Drug Delivery Devices market size has reached to $18.54 billion in 2025 • Expected to grow to $29.91 billion in 2030 at a compound annual growth rate (CAGR) of 9.7% • Growth Driver: Diabetes As A Catalyst Is Driving Growth In The Needle-Free Drug Delivery Devices Market • Market Trend: Advancements In Dual Chamber Inhalers Revolutionize The Needle-Free Drug Delivery Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Needle-Free Drug Delivery Devices Market?

Needle-free drug delivery devices refer to medical tools designed to administer medication without traditional needles. They offer an alternative means of delivering drugs, vaccines, or therapeutic agents into the body through the skin or mucosal membranes. These devices aim to reduce patient discomfort and the risk of needle-related injuries. The main types of needle-free drug delivery devices include inhalers, jet injectors, novel needles, transdermal patches, and others. Inhalers are portable devices that deliver medication directly into the lungs through a mist or spray. These are used for several applications, such as pain management, vaccine delivery, pediatric injections, insulin delivery, and others, by various end-users, including hospitals and clinics and home healthcare.

What Is The Needle-Free Drug Delivery Devices Market Growth Forecast?

The needle-free drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $29.91 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to increasing chronic disease prevalence, growing adoption of self-administration therapies, expansion of telemedicine and remote care, rising demand for minimally invasive drug delivery, advancements in microneedle and transdermal technologies. Major trends in the forecast period include growing demand for painless drug delivery methods, increasing adoption of home-based drug delivery solutions, rising use of needle-free devices in pediatric applications, growth in self-administration treatments for chronic diseases, expansion of needle-free vaccine delivery systems.

Global Needle-Free Drug Delivery Devices Market Segmentation

1) By Device Type: Inhalers, Jet Injectors, Novel Needles, Transdermal Patches 2) By Application: Pain Management, Vaccine Delivery, Pediatric Injections, Insulin Delivery, Other Applications 3) By End-User: Hospitals And Clinics, Home Healthcare Subsegments: 1) By Inhalers: Dry Powder Inhalers (DPI), Metered Dose Inhalers (MDI), Nebulizers 2) By Jet Injectors: High-Pressure Jet Injectors, Spring-Powered Jet Injectors, Battery-Operated Jet Injectors 3) By Novel Needles: Micro-Needle Arrays, Nano-Needle Arrays 4) By Transdermal Patches: Microneedle Patches, Conventional Patches

What Is The Driver Of The Needle-Free Drug Delivery Devices Market?

The increasing prevalence of diabetes is expected to propel the growth of the needle-free drug delivery device market going forward. Diabetes presents as a persistent health issue marked by high blood sugar levels, stemming from inadequate insulin production or the body's ineffective utilization of insulin. Diabetes is on the rise due to sedentary lifestyles, unhealthy dietary habits, genetic predisposition, urbanization, and aging populations, compounded by limited access to healthcare and rising obesity rates worldwide. Needle-free drug delivery devices provide an alternative to conventional injections for insulin administration in diabetes care. It uses technologies such as jet injectors or transdermal patches that deliver insulin through the skin without needles, alleviating the discomfort and anxiety often linked with injections and enhancing comfort levels. For instance, in June 2024, according to the National Health Service, a UK-based government department, in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This represents a significant increase compared to 3,065,825 in 2022, highlighting a rise of nearly 20%. Therefore, the increasing prevalence of diabetes is driving the growth of the needle-free drug delivery device industry.

Key Players In The Global Needle-Free Drug Delivery Devices Market

Major companies operating in the needle-free drug delivery devices market are 3M Company, Medtronic plc, Novo Nordisk AS, Becton Dickinson and Company, Insulet Corporation, MannKind Corporation, Med-Jet Inc., Portal Instruments, PharmaJet, National Medical Products Inc., Mika Medical Co. Ltd., Medical International Technology Inc. (MTI), NanoPass Technologies Ltd., PenJet Corporation, Akra Dermojet S.A., NuGen Medical Devices Inc., Crossject SA, Injex Pharma AG, Bayer AG, Antares Pharma Inc., Inovio Pharmaceuticals Inc.

Global Needle-Free Drug Delivery Devices Market Trends and Insights

Major companies operating in the needle-free drug delivery device market are focusing on advanced solutions, such as dual chamber inhalers, to enhance the efficacy and ease of administration and cater to the evolving needs of patients and healthcare providers. A dual-chamber inhaler is a device with two compartments that can hold different medications separately. This design allows for the combination of multiple drugs in a single inhaler, streamlining treatment and improving convenience for patients. For instance, in April 2024, Berry Global, a US-based plastic manufacturing company, introduced the BerryHaler, a cutting-edge dry powder inhaler (DPI) designed to revolutionize patient-centered healthcare solutions. This dual-chamber inhaler boasts a dose counter, ensuring precise medication administration. Its all-plastic construction, devoid of any metal parts, makes it ideal for complex inhalation treatments, simplifying dosage and combining multiple drugs effectively. The advanced features include a bi-directional mouthpiece cover for convenience and hygiene, along with audible signals to indicate proper usage. The integrated dose counter aids in monitoring medication usage accurately, preventing dosage errors.

What Are Latest Mergers And Acquisitions In The Needle-Free Drug Delivery Devices Market?

In November 2025, Harrow IP LLC, a US-based provider of ophthalmic disease management solutions, acquired Melt Pharmaceuticals for an undisclosed amount. With this acquisition, Harrow aims to expand its portfolio into the needle-free procedural sedation market by integrating Melt’s non-opioid, non-intravenous sublingual sedation candidates and strengthening its presence across hospital, outpatient, and office-based procedural care. Melt Pharmaceuticals is a US-based provider of innovative sublingual, needle-free sedation therapies.

Regional Outlook

North America was the largest region in the needle-free drug delivery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Needle-Free Drug Delivery Devices Market?

The needle-free drug delivery devices market consists of sales of nasal sprays, buccal patches, and oral inhalers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Needle-Free Drug Delivery Devices Market Report 2026?

The needle-free drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the needle-free drug delivery devices industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.